Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics
暂无分享,去创建一个
Paweł Wiczling | K. Kusza | P. Wiczling | J. Cywinski | Edmund Grześkowiak | A. Bienert | E. Grześkowiak | Agnieszka Bienert | Jacek B Jacek Cywiński | Krzysztof Kusza | Edmund Grzśkowiak
[1] Harald Ihmsen. Population Pharmacokinetics of Propofol , 2000 .
[2] A. Dawidowicz,et al. Influence of propofol concentration in human plasma on free fraction of the drug. , 2006, Chemico-biological interactions.
[3] E. García-Martín,et al. Polymorphic drug metabolism in anaesthesia. , 2009, Current drug metabolism.
[4] B. Lacarelle,et al. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. , 1990, Anesthesiology.
[5] J. Vuyk. Pharmacodynamics in the elderly. , 2003, Best practice & research. Clinical anaesthesiology.
[6] 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction , 2002, European Journal of Clinical Pharmacology.
[7] K. Patel,et al. Rapid emergence does not explain agitation following sevoflurane anaesthesia in infants and children: a comparison with propofol , 2003, Paediatric anaesthesia.
[8] G. Orliaguet,et al. [Propofol infusion syndrome]. , 2010, Annales francaises d'anesthesie et de reanimation.
[9] Michel Struys,et al. Pharmacokinetics in obese patients , 2004 .
[10] G. Snyder,et al. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. , 2010, British journal of anaesthesia.
[11] Donald Bucher,et al. Propofol infusion syndrome: a rare complication with potentially fatal results. , 2008, Critical care nurse.
[12] R. Kaliszan,et al. Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery , 2012, Pharmacological reports : PR.
[13] R. Farinotti,et al. Propofol Infusion for Maintenance of Anesthesia in Morbidly Obese Patients Receiving Nitrous Oxide A Clinical and Pharmacokinetic Study , 1993, Anesthesiology.
[14] B. Chi,et al. Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia , 2009, BMC health services research.
[15] J Schüttler,et al. Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.
[16] S L Shafer,et al. Pharmacokinetics and Pharmacodynamics of Propofol Infusions during General Anesthesia , 1988, Anesthesiology.
[17] J. DeJongh,et al. Disease Severity Is a Major Determinant for the Pharmacodynamics of Propofol in Critically Ill Patients , 2008, Clinical pharmacology and therapeutics.
[18] Jinbao Li,et al. Anesthesia awareness and the bispectral index. , 2008, The New England journal of medicine.
[19] M. Struys,et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. , 2010, British journal of anaesthesia.
[20] G. Kenny,et al. 'Paedfusor' pharmacokinetic data set. , 2005, British journal of anaesthesia.
[21] P. Steen,et al. Bispectral index, predicted and measured drug levels of target‐controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence , 2000, Acta anaesthesiologica Scandinavica.
[22] Isabelle Murat,et al. Maturational pharmacokinetics of single intravenous bolus administration of propofol during childhood: 9AP5-1 , 2007 .
[23] K. Morita,et al. Do the kidneys contribute to propofol elimination? , 2008, British journal of anaesthesia.
[24] S. Shafer,et al. The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.
[25] Fumio Goto,et al. Changes in Drug Plasma Concentrations of an Extensively Bound and Highly Extracted Drug, Propofol, in Response to Altered Plasma Binding , 2004, Clinical pharmacology and therapeutics.
[26] I. Constant,et al. Which model for propofol TCI in children , 2010, Paediatric anaesthesia.
[27] J. Schüttler,et al. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients , 1995, Intensive Care Medicine.
[28] M. Avram,et al. What determines anesthetic induction dose? It's the front-end kinetics, doctor! , 1999, Anesthesia and analgesia.
[29] T. Short,et al. The use of propofol infusions in paediatric anaesthesia: a practical guide , 1999, Paediatric anaesthesia.
[30] Jeffrey C. Sigl,et al. Anesthetic Management and One-Year Mortality After Noncardiac Surgery , 2005, Anesthesia and analgesia.
[31] M. Todd,et al. Practice Advisory for Intraoperative Awareness and Brain Function Monitoring: A Report by the American Society of Anesthesiologists Task Force on Intraoperative Awareness , 2006, Anesthesiology.
[32] R N Upton,et al. Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration. , 1999, Anesthesia and analgesia.
[33] J. Brichant. [The Helsinki Declaration on Patient Safety in Anaesthesiology]. , 2010, Acta anaesthesiologica Belgica.
[34] P. Pévet,et al. Reciprocal Relationships between General (Propofol) Anesthesia and Circadian Time in Rats , 2007, Neuropsychopharmacology.
[35] M. White,et al. Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. , 2003, British journal of anaesthesia.
[36] J. Crooks,et al. Pharmacokinetics in the Elderly , 1976, Clinical pharmacokinetics.
[37] P. Glass,et al. Pharmacokinetics in the elderly. , 2003, Best practice & research. Clinical anaesthesiology.
[38] J. Bruhn,et al. Depth of anaesthesia monitoring: what's available, what's validated and what's next? , 2006, British journal of anaesthesia.
[39] K. Borowicz,et al. Melatonin in experimental seizures and epilepsy , 2011, Pharmacological reports : PR.
[40] C. Minto,et al. Contributions of PK/PD Modeling to Intravenous Anesthesia , 2008, Clinical pharmacology and therapeutics.
[41] P. Wiczling,et al. Influence of Time of Day on Propofol Pharmacokinetics and Pharmacodynamics in Rabbits , 2011, Chronobiology international.
[42] Mats O. Karlsson,et al. A two-compartment effect site model describes the bispectral index after different rates of propofol infusion , 2010, Journal of Pharmacokinetics and Pharmacodynamics.
[43] C. Reilly,et al. Evaluation of the predictive performance of a ‘Diprifusor’ TCI system , 1998, Anaesthesia.
[44] K. Kusza,et al. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I–III patients , 2011, Arzneimittelforschung.
[45] Thomas V Perneger,et al. The Swiss cheese model of safety incidents: are there holes in the metaphor? , 2005, BMC health services research.
[46] C. Saint-Maurice,et al. Pharmacokinetics of propofol in young children after a single dose. , 1989, British journal of anaesthesia.
[47] Steven Edward Kern,et al. The Influence of Hemorrhagic Shock on Propofol: A Pharmacokinetic and Pharmacodynamic Analysis , 2003, Anesthesiology.
[48] J. Gross,et al. Textbook of Intravenous Anesthesia , 1997 .
[49] P. Kam,et al. Propofol infusion syndrome , 2007, Anaesthesia.
[50] M. Struys,et al. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. , 2009, British journal of anaesthesia.
[51] C. Perry,et al. Propofol: a review of its use in intensive care sedation of adults. , 2003, CNS drugs.
[52] N. Morton,et al. Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.
[53] S L Shafer,et al. The influence of age on propofol pharmacodynamics. , 1999, Anesthesiology.
[54] P. Boon,et al. Influence of Hypovolemia on the Pharmacokinetics and the Electroencephalographic Effect of Propofol in the Rat , 2000, Anesthesiology.
[55] E. Olofsen,et al. Mixed-effects Modeling of the Influence of Alfentanil on Propofol Pharmacokinetics , 2004, Anesthesiology.
[56] G. Orliaguet,et al. Le syndrome de perfusion du propofol , 2010 .
[57] I. Murat,et al. Pharmacokinetics of Propofol after a Single Dose in Children Aged 1–3 Years with Minor Burns: Comparison of Three Data Analysis Approaches , 1996, Anesthesiology.
[58] Björn Lemmer,et al. Disturbance of Circadian Rhythms in Analgosedated Intensive Care Unit Patients with and without Craniocerebral Injury , 2007, Chronobiology international.
[59] N. Morton,et al. Overview of total intravenous anesthesia in children , 2010, Paediatric anaesthesia.
[60] C. Royse. Is depth of anesthesia, as assessed by the bispectral index, related to postoperative cognitive dysfunction and recovery? , 2007, Anesthesia and analgesia.
[61] G T Lewis,et al. Induction and maintenance of propofol anaesthesia , 1988, Anaesthesia.
[62] P. Steen,et al. Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. , 2003, British journal of anaesthesia.
[63] Y. Nakata,et al. Emergence Agitation After Sevoflurane Versus Propofol in Pediatric Patients , 2000 .
[64] Kotaro Kaneda,et al. Population pharmacokinetics of a propofol bolus administered in patients with major burns. , 2010, Burns : journal of the International Society for Burn Injuries.
[65] J. DeJongh,et al. Population pharmacokinetic and pharmacodynamic modeling of propofol for long‐term sedation in critically ill patients: A comparison between propofol 6% and propofol 1% , 2002, Clinical pharmacology and therapeutics.
[66] I. Constant,et al. Pharmacokinetic-Pharmacodynamic Modeling of Propofol in Children , 2010, Anesthesiology.
[67] K. Kusza,et al. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients , 2010, Journal of Pharmacokinetics and Pharmacodynamics.
[68] D. Tibboel,et al. Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients , 2008, European Journal of Clinical Pharmacology.
[69] J. Swanson. Pharmacokinetics / Pharmacodynamics , 2011 .
[70] H F Nicodemus,et al. The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.